NASDAQ:APEN • US03767D1081
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APOLLO ENDOSURGERY INC (APEN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-01-23 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2023-01-04 | Stifel | Downgrade | Buy -> Hold |
| 2022-11-30 | Lake Street | Downgrade | Buy -> Hold |
| 2022-05-04 | Stephens & Co. | Maintains | Overweight |
| 2022-02-23 | Stifel | Maintains | Buy |
| 2021-12-15 | Cowen & Co. | Initiate | Outperform |
| 2021-12-09 | Stifel | Initiate | Buy |
| 2021-09-09 | Stephens & Co. | Initiate | Overweight |
| 2021-06-14 | Piper Sandler | Maintains | Overweight |
| 2021-05-17 | Lake Street | Initiate | Buy |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 42.05M -17.08% | 62.989M 49.80% | 76.856M 22.01% | 91.023M 18.43% | 111.2M 22.17% | 184.47M 65.89% | |
| EBITDA YoY % growth | -12.06M 51.88% | -15.967M -32.40% | -24.856M -55.67% | -17.33M 30.28% | -13.182M 23.94% | N/A | |
| EBIT YoY % growth | -15.79M 45.78% | -19.199M -21.59% | -27.822M -44.91% | -29.618M -6.46% | -26.049M 12.05% | -27.671M -6.22% | |
| Operating Margin | -37.55% | -30.48% | -36.20% | -32.54% | -23.43% | -15.00% | |
| EPS YoY % growth | -1.04 31.58% | -0.89 14.42% | -0.98 -9.99% | -0.85 13.10% | -0.73 13.67% | N/A |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 -5.24% | -0.22 16.31% | -0.20 28.36% | -0.19 15.35% | -0.19 12.31% | -0.18 15.62% | -0.14 28.81% | -0.13 31.58% |
| Revenue Q2Q % growth | 20.25M 21.53% | 22.921M 18.72% | 23.452M 19.82% | 24.527M 15.07% | 23.964M 18.34% | 26.406M 15.20% | 27.393M 16.80% | 29.342M 19.63% |
| EBITDA Q2Q % growth | -5.14M 21.00% | -4.923M 3.47% | -4.389M -8.54% | -4.318M 8.91% | -5.145M -0.10% | -4.378M 11.07% | -2.857M 34.91% | -2.175M 49.63% |
| EBIT Q2Q % growth | -7.806M -7.72% | -7.612M -15.72% | -7.138M -13.46% | -6.781M 12.00% | -7.692M 1.47% | -7.024M 7.73% | -5.506M 22.86% | -4.871M 28.18% |
All data in USD
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.
APOLLO ENDOSURGERY INC (APEN) will report earnings on 2023-05-01.
The consensus EPS estimate for the next earnings of APOLLO ENDOSURGERY INC (APEN) is -0.22 USD and the consensus revenue estimate is 20.25M USD.
The expected long term growth rate for APOLLO ENDOSURGERY INC (APEN) is 33.84%.